🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This research trial studies the incidence of human papilloma virus (HPV) in...
Status
Withdrawn
Location
UCSF Medical Center-Parnassus
Start Date
2027-04-30
Trial ID
NCT04142398
This study compares different screening approaches to detect abnormal cell ...
Status
Active Not Recruiting
Location
Instituto Dermatológico Dominicano y Cirugía de Piel (IDCP) "Dr. Huberto Bogaert Diaz"
Start Date
2022-11-14
Trial ID
NCT05556772
Treatments Being Tested
RATIONALE: Diagnostic procedures, such as anal swab collection, digital rec...
Status
Completed
Location
Rebecca and John Moores UCSD Cancer Center
Start Date
2008-05-14
Trial ID
NCT00695422
The purpose of this research is to study different strategies to identify w...
Status
Completed
Location
The Ponce Center
Start Date
2016-07
Trial ID
NCT02873741
Treatments Being Tested
The treatment of fecal incontinence after low anterior resection is problem...
Status
Unknown
Location
Istanbul Medipol University Medical School
Start Date
2019-05-15
Trial ID
NCT04063293
Treatments Being Tested
The purpose of our study is to determine if an association exists between t...
Status
Active Not Recruiting
Location
Tampa General Hospital
Start Date
2020-02-18
Trial ID
NCT04223102
Treatments Being Tested
This is a hypothesis-generating pilot study. The intent is to model the imp...
Status
Terminated
Location
The Emory Clinic
Start Date
2017-10-02
Trial ID
NCT03043339
This phase II trial studies how well nivolumab with or without ipilimumab w...
Status
Active Not Recruiting
Location
Los Angeles General Medical Center
Start Date
2015-05-13
Trial ID
NCT02314169
Treatments Being Tested
The main purpose of the study is to evaluate the effectiveness and safety o...
Status
Completed
Location
Praktyka Lekarska Małgorzata Uchman-Musielak
Start Date
2019-10-15
Trial ID
NCT04181840
The purpose of this study is to determine the maximum tolerated dose of ima...
Status
Completed
Location
Institut Bergonié
Start Date
2009-02-09
Trial ID
NCT01046487